Shopping Cart 0
Cart Subtotal
USD 0

Lead Discovery Center GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Lead Discovery Center GmbH (LDC), a subsidiary of Max Planck Innovation GmbH is a biomedical research company that offers development of novel drugs and therapies. The company develops drugs and therapies for diseases such as neurodegenerative cardiovascular diseases, cancer, inflammatory disorders, inflammatory disorders and infections, metabolic syndrome, and unmet clinical needs. It offers services such as medical chemistry through organic synthesis, design of focused compound libraries, establishment of structure-activity, computer-aided rational drug design, and structure-property relationships, among others. LDC offers services through its departments including assay development and screening, medicinal chemistry, biology and pharmacology. The company collaborates with universities and academic research institutions for professional drug discovery support. LDC is headquartered in Dortmund, Germany.

Lead Discovery Center GmbH-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

UGISense Raises Funds through Financing 12

UGISense to Raise USD1.3 Million Venture Financing 13

Partnerships 14

APEIRON Biologics Enters into Agreement with Lead Discovery Center 14

Grunenthal, Lead Discovery Center, Max-Planck Innovation and Max Planck Institute of Experimental Medicine Enter into Agreement 15

Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Enter into Research Agreement 16

Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 17

Lead Discovery Center to Enter into Development Agreement with UGISense 18

Lead Discovery Center Enters into Research Agreement with McGill University 19

LDC, Max Planck Innovation Enters into Agreement with Boehringer Ingelheim 20

Lead Discovery Center to Enter into Drug Discovery Agreement with Roche 21

Lead Discovery Center Partners with Infinity Pharma 22

Johnson & Johnson Innovation Partners with Lead Discovery Center 23

Qurient Enters into Agreement with Lead Discovery Center 24

AstraZeneca Expands Drug Discovery Agreement with Lead Discovery Center 25

Lead Discovery Center Enters into Research Agreement with Helmholtz Center 26

Lead Discovery Center Enters into Agreement with UiT The Arctic University of Norway 27

Lead Discovery Center Partners with Helmholtz Association of German Research Centres 28

Daiichi Sankyo Enters Into Drug Discovery Agreement With Lead Discovery Center 29

Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 30

Merck Serono Enters Into Discovery Agreement With Lead Discovery Center 31

AstraZeneca Enters Into Drug Discovery Agreement With Lead Discovery Center 32

Licensing Agreements 33

Sotio Enters into Licensing Agreement with Lead Discovery Center 33

Lead Discovery Center Enters into Licensing Agreement with Qurient 34

Qurient Enters Into Licensing Agreement with Max Planck Society and Lead Discovery Center 35

Max Planck Institute of Biochemistry And Lead Discovery Center Enter Into Licensing Agreement With Qurient For Kinase Inhibitor 36

Lead Discovery Center GmbH-Key Competitors 38

Lead Discovery Center GmbH-Key Employees 39

Lead Discovery Center GmbH-Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Joint Venture 40

Appendix 41

Methodology 41

About GlobalData 41

Contact Us 41

Disclaimer 41


List Of Figure

List of Figures

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Key Facts 2

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Lead Discovery Center GmbH, Deals By Therapy Area, 2012 to YTD 2018 8

Lead Discovery Center GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

UGISense Raises Funds through Financing 12

UGISense to Raise USD1.3 Million Venture Financing 13

APEIRON Biologics Enters into Agreement with Lead Discovery Center 14

Grunenthal, Lead Discovery Center, Max-Planck Innovation and Max Planck Institute of Experimental Medicine Enter into Agreement 15

Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Enter into Research Agreement 16

Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 17

Lead Discovery Center to Enter into Development Agreement with UGISense 18

Lead Discovery Center Enters into Research Agreement with McGill University 19

LDC, Max Planck Innovation Enters into Agreement with Boehringer Ingelheim 20

Lead Discovery Center to Enter into Drug Discovery Agreement with Roche 21

Lead Discovery Center Partners with Infinity Pharma 22

Johnson & Johnson Innovation Partners with Lead Discovery Center 23

Qurient Enters into Agreement with Lead Discovery Center 24

AstraZeneca Expands Drug Discovery Agreement with Lead Discovery Center 25

Lead Discovery Center Enters into Research Agreement with Helmholtz Center 26

Lead Discovery Center Enters into Agreement with UiT The Arctic University of Norway 27

Lead Discovery Center Partners with Helmholtz Association of German Research Centres 28

Daiichi Sankyo Enters Into Drug Discovery Agreement With Lead Discovery Center 29

Lead Discovery Center, Centre for Drug Design and Discovery and Axxam Form Joint Venture 30

Merck Serono Enters Into Discovery Agreement With Lead Discovery Center 31

AstraZeneca Enters Into Drug Discovery Agreement With Lead Discovery Center 32

Sotio Enters into Licensing Agreement with Lead Discovery Center 33

Lead Discovery Center Enters into Licensing Agreement with Qurient 34

Qurient Enters Into Licensing Agreement with Max Planck Society and Lead Discovery Center 35

Max Planck Institute of Biochemistry And Lead Discovery Center Enter Into Licensing Agreement With Qurient For Kinase Inhibitor 36

Lead Discovery Center GmbH, Key Competitors 38

Lead Discovery Center GmbH, Key Employees 39

Lead Discovery Center GmbH, Subsidiaries 40

Lead Discovery Center GmbH, Joint Venture 40

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Lead Discovery Center GmbH, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.